Biochemical changes during moduretic treatment of hypertension in African patients.
Ahaneku
J E
JE
Department of Chemical Pathology, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
Taylor
G O
GO
Walker
O
O
Agbedana
E O
EO
Salako
L A
LA
D000328:Adult; D000368:Aged; D000584:Amiloride / Q000009:adverse effects* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D001798:Blood Proteins / Q000378:metabolism; D002118:Calcium / Q000097:blood; D002712:Chlorides / Q000097:blood; D003404:Creatinine / Q000097:blood; D004232:Diuretics / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects* / Q000627:therapeutic use; D006973:Hypertension / Q000097:blood* / Q000188:drug therapy*; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D009549:Nigeria; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood; D014508:Urea / Q000097:blood
D000959:Antihypertensive Agents; D001786:Blood Glucose; D001798:Blood Proteins; D002712:Chlorides; D004232:Diuretics; D006852:Hydrochlorothiazide; D000584:Amiloride; D014508:Urea; D012964:Sodium; D003404:Creatinine; D011188:Potassium; D002118:Calcium